MHRA Drug Safety Update — topical steroidsPeacock, DianeBritish Journal of General Practice
Implementing drug safety updatesImplementing drug safety updatesIn August 2007, the Medicines and Healthcare products Regulatory Agency (MHRA) launched its monthly Drug Safety Update.1 As would be expected from a publication produced by the MHRA, it is based on robust analysis of pharmacovigilance dat...
Comment on the recent Drug Safety Update for August 2008 published by the Medicines and Healthcare products Regulatory Agency (MHRA)doi:10.1136/bmj.331.7515.498mediastinal tumorsschwannomaphrenic nerveclear cell chondrosarcomaWhile John Starr was working as a senior registrar at the Hammersmit...
Evaluating the communication within fire and rescue services and the NHS on the fire risk of emollients in accordance of the MHRA safety update The Medicines and Healthcare products Regulatory Agency update in 2018 reported 50 fatal fires linked with emollient use. It detailed the fire risk and ...
It remains to be seen whether Bayer will be allowed to use the terms "unreliable" and "may not be reliable" as regards the Lidegaard publication and the Van Hylckama Vlieg publication in Europe, as it apparently intends to do in the U.S. The April 2010 MHRADrug Safety Updatearticle abov...
As we are focusing in this article on the fact that Xeljanz increases infection risks, we limit our review to that aspect of the MHRA Xeljanz Drug Safety Update report. In relevant part, here is what is being pointed out: [Xeljanz (tofacitinib)] is known to increase ...
The Yellow Card Scheme is used by the Medicines and Healthcare products Regulatory Agency (MHRA) to monitor the safety of currently licensed medicines and vaccines in the UK and is part of routine pharmacovigilance. Currently, health professionals (doctors, dentists, nurses, and pharmacists), corone...
Human papillomavirus vaccination catch-up campaign in 2009 for girls born in 1993 to 1996 in the Netherlands: results of the post-marketing safety surveillance. 2011. The Medicines and Healthcare products Regulatory Agency (MHRA). Cervarix (HPV vaccine): update on UK safety covering the first ...
MHRA | UK Michael Bean Johnson & Johnson Michael Von Forstner Sobi | Switzerland Mateja Pranjić GSK | UK VIEW ALL SPEAKERS To Speak At PV Europe CongressClick Here International Companies Attending PV Europe WHO SHOULD ATTEND Pharmacovigilance Europe Congress attracts senior level attendees from lead...
The Smart Safety Surveillance (3S) concept is based on the understanding that, when faced with competing pharmacovigilance priorities, countries will have